|
VRTX | Vertex Pharmaceuticals Inc / Ma |
|
|
VRTX | Vertex Pharmaceuticals Inc / Ma |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.16 |
| Leverage | 30.34% |
| Market Cap | $ 111.6B |
| PE | 30.46 |
| Dividend Yield | 0.00% |
| Profit | $ 3.7B |
| Margin | 31.43% |
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.